SETH CARTER: Open Payments
NPI 1689024598 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,643 in 143 payments from 30 companies in 2025. Trend: 2023 $1,979 · 2024 $2,572 · 2025 $6,643
Consulting: $4,050Food & beverage: $2,588Education: $5
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $4,306 |
| PFIZER INC. | 16 | $228 |
| Novo Nordisk Inc | 13 | $206 |
| AstraZeneca Pharmaceuticals LP | 11 | $195 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $189 |
| Teva Pharmaceuticals USA, Inc. | 11 | $185 |
| GlaxoSmithKline, LLC. | 15 | $170 |
| Exact Sciences Corporation | 7 | $160 |
| ABBVIE INC. | 7 | $139 |
| ACUMED LLC | 1 | $128 |
Products named: KISUNLA, CAPLYTA, AUSTEDO XR, TRELEGY ELLIPTA, JARDIANCE, NURTEC ODT, UBRELVY, InFrame Implant.
Industry payments across PA — which companies pay providers there.
